PCN76 - BUDGET IMPACT ANALYSIS OF AFATINIB FOR THE FIRST-LINE TREATMENT OF ADVANCED OR METASTATIC NON–SMALL-CELL LUNG CANCER IN CHINA
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.158
https://www.valueinhealthjournal.com/article/S1098-3015(18)33458-2/fulltext
Title :
PCN76 - BUDGET IMPACT ANALYSIS OF AFATINIB FOR THE FIRST-LINE TREATMENT OF ADVANCED OR METASTATIC NON–SMALL-CELL LUNG CANCER IN CHINA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33458-2&doi=10.1016/j.jval.2018.09.158
First page :
Section Title :
Open access? :
No
Section Order :
982